Related by context. All words. (Click for frequent words.) 67 proliferative disorders 66 busulfan 66 antiangiogenic drugs 65 adult mesenchymal stem 65 chimeric monoclonal antibody 65 myeloproliferative diseases 65 malignant lymphomas 65 Dacogen decitabine 65 immunosuppressive therapies 65 erythropoietic 65 idiopathic myelofibrosis 65 anti angiogenic agents 65 NF kB pathway 65 CD4 + T lymphocytes 64 GCase 64 monoclonal anti 64 granulocyte 64 myeloproliferative disorders 64 alpha interferons 64 pro angiogenic 64 immune modulator 64 Gleevec resistant 64 imatinib Gleevec 64 mTOR inhibitors 64 subcutaneous immunoglobulin 64 epithelial tumors 64 MGd 64 Orally administered 64 Cyclosporin 64 immune modulating 64 immunopathology 64 interleukins 63 Neulasta ® 63 neuroendocrine cancers 63 receptor tyrosine kinase inhibitor 63 immunodeficiency disorders 63 beta interferons 63 Pemetrexed 63 inhibitor RG# 63 dasatinib Sprycel 63 Leukine ® 63 papillary renal cell carcinoma 63 colon carcinoma 63 TNF alpha antagonist 63 ocular disorders 63 prostate carcinoma 63 trans retinoic acid 63 Ontak 63 polycythemia vera PV 63 immuno modulatory 63 ERK signaling 63 Vidaza azacitidine 63 proteasome inhibitor 63 histone deacetylase HDAC inhibitors 63 neutrophil counts 63 Th2 cytokines 63 recombinant erythropoietin 63 basiliximab 63 VEGF inhibitors 63 cytokine IL 62 depsipeptide 62 monoclonal 62 malignant ascites 62 gastrointestinal stromal tumors GISTs 62 verteporfin 62 humanized monoclonal antibodies 62 benzimidazole 62 mesenchymal stem cell 62 humanised monoclonal antibody 62 immunotoxins 62 lymphoid organs 62 Squalamine 62 NQO1 62 metastatic neuroendocrine tumors 62 gastric carcinoma 62 rituximab Rituxan 62 recombinant enzyme 62 oligodendrocyte progenitor cells 62 pegfilgrastim 62 nicotinic acetylcholine receptor 62 bevacizumab Avastin ® 62 calcineurin inhibitor 62 elastase 62 metastatic uveal melanoma 62 colony stimulating factor 62 androgen receptor AR 62 microtubule inhibitor 62 tumoral 62 Bleomycin 62 Aviptadil 62 cytotoxins 62 LHRH agonists 62 thalidomide Thalomid 62 antiemetics 62 Gleevec imatinib 62 apoptotic pathway 62 filgrastim 62 mesenchymal cell 62 lung carcinomas 62 chemoresistance 62 keratinocyte 62 targeted antifolate 62 sodium thiosulfate STS 62 uricase 62 nucleoside analogs 62 Prolastin C 62 EGFR inhibitors 62 bortezomib Velcade 62 CYP #A# 62 ara C 62 post transplant lymphoproliferative 62 prostaglandin synthesis 62 von Willebrand 62 cytotoxics 62 lymphomas leukemias 62 Interferon alpha 62 GW# [003] 62 cytotoxic therapies 62 kidney urologic 62 Kinoid 61 deacetylase inhibitors 61 invasive ductal 61 prostaglandin D2 61 docetaxel Taxotere ® 61 erlotinib Tarceva ® 61 basic fibroblast 61 chemotherapy induced neutropenia 61 alpha interferon 61 cisplatin resistant 61 lapatinib Tykerb 61 haematologic 61 adipogenic 61 adrenal hormone 61 TNF α 61 potent inhibitors 61 Hematopoietic 61 paclitaxel Taxol 61 etoposide 61 A3 adenosine receptor 61 purified recombinant 61 receptors EGFR 61 OHR/AVR# 61 radiosensitivity 61 essential thrombocythemia 61 anti CD3 61 isoproterenol 61 grade cervical intraepithelial 61 immune modulators 61 bone marrow suppression 61 humoral responses 61 p# MAP kinase inhibitor 61 pediatric acute lymphoblastic 61 colorectal carcinoma 61 antiproliferative effects 61 somatostatin analogs 61 Fibroblast Growth Factor Receptor 61 Neuropeptide Y 61 cardiotoxic 61 patients undergoing chemotherapy 61 vasoactive 61 serous ovarian cancer 61 bone marrow stromal cells 61 KRAS mutant 61 taxane resistant 61 EGFR HER2 61 carcinoid tumors 61 gonadotropin releasing hormone GnRH 61 haematopoietic 61 topical formulations 61 hypereosinophilic syndrome 61 uPA 61 factor TNF 61 allogeneic HSCT 61 potent cytotoxic 61 histological subtype 61 cells PBMC 61 nonsmall cell lung cancer 61 ERK pathway 61 humanized monoclonal 61 chemokine receptor 61 nanomolar range 61 fibrin deposition 61 imatinib resistance 61 BCG refractory 61 SSc 61 interleukin IL -# 61 Neulasta pegfilgrastim 61 urothelial bladder cancer 61 hematologic disorders 61 erythropoiesis 61 Leukemias 61 chemosensitivity 61 rFVIIa 61 Vidaza ® 61 griseofulvin 61 mediated inhibition 61 pheochromocytoma 61 metastatic lymph nodes 61 cytokines chemokines 61 mononuclear 61 cells hESCs 61 soluble tumor necrosis 61 Fas ligand 61 investigational monoclonal antibody 61 antimetabolites 61 Treg cell 61 Candida infection 61 monocytic 61 thyroid hormone receptor 61 Myelodysplastic syndromes MDS 61 reteplase 61 interferon IFN 61 kallikrein 61 Interferon beta 61 histone deacetylase inhibitor 61 EGF receptor 61 neoplastic diseases 61 infused intravenously 61 EGFRIs 61 pancreatic adenocarcinoma 61 Sudhir Agrawal D.Phil 61 hematopoietic cells 60 demethylating agent 60 MAGE A3 ASCI 60 lymphoma subtypes 60 Neupogen ® 60 collagenase 60 serotonin synthesis 60 flavopiridol 60 efalizumab 60 secondary hyperparathyroidism 60 mononuclear cells 60 radiotherapeutic 60 sclerosing 60 plasma kallikrein 60 DFMO 60 CellCept mycophenolate mofetil 60 skeletal metastases 60 inhibiting tumor 60 asparaginase 60 anti CD3 antibody 60 EGFR tyrosine kinase inhibitors 60 nitroprusside 60 novel peptide 60 tryptase 60 premalignant 60 monocytes macrophages 60 lytic 60 PI3K Akt 60 intradermal injection 60 tyrosine kinase inhibitors TKIs 60 effector function 60 myelofibrosis polycythemia vera 60 CDDO Im 60 leukocytosis 60 Cytotoxic 60 induced anemia 60 refractory prostate cancer 60 ANCA associated 60 idiopathic thrombocytopenic purpura ITP 60 fluvastatin 60 corticosteroid dexamethasone 60 mineralocorticoid 60 heparanase 60 anti androgens 60 hypomethylating agent 60 gamma secretase inhibitor 60 lenalidomide Revlimid 60 pamidronate 60 Sertoli cells 60 beta lactams 60 cytotoxic effects 60 beta lactam antibiotic 60 neutrophil count 60 induce remission 60 basophils 60 redox active 60 cyclosporin 60 granulocyte colony stimulating 60 myeloperoxidase 60 protein CETP 60 pentostatin 60 Angiotensin Converting Enzyme 60 autologous SCT 60 hormone gastrin 60 squamous cell lung cancer 60 hedgehog pathway 60 pan HDAC inhibitor 60 c MET 60 Fibroblast 60 sodium stibogluconate 60 antimitotic 60 taxane chemotherapy 60 amyloid toxicity 60 thymosin beta 4 60 dexrazoxane 60 polycythemia vera essential thrombocythemia 60 Factor VIIa 60 cardiometabolic disorders 60 transgenic rats 60 Calcitonin 60 factor G CSF 60 prostate carcinomas 60 tyrosine kinase inhibitor 60 ALK inhibitors 60 Factor VEGF 60 mutated KRAS gene 60 chemotherapeutics 60 carcinoid 60 G CSFs 60 Lymphocytes 60 iron chelators 60 selectively inhibited 60 fibrocytes 60 Allogeneic 60 vWF 60 prostate cancer PCa 60 interferons 60 erlotinib Tarceva 60 bFGF 60 HepDirect prodrug 60 sphingolipid 60 engineered RAP peptides 60 neurotrophic factors 60 antiangiogenic therapy 60 metastatic malignant 60 plasma albumin 60 isoenzyme 60 epithelial cancers 60 protein kinase inhibitors 60 Janus Kinase 60 diagnostic biomarker 60 TMP SMX 60 Cytoxan ® 60 allograft rejection 60 mycosis fungoides 60 gastrointestinal perforation 60 Glucocorticoids 60 JAK2 mutation 60 cytomegalovirus CMV 60 bryostatin 60 thrombocytopenic 60 Mesenchymal 60 TLR9 agonist 60 intravenous bisphosphonates 60 Myelodysplastic Syndrome MDS 60 LHRH receptor positive 60 synthetic analogues 60 renoprotective 60 biologic pathway 60 urothelial cancer 60 HEK# 60 alkylating agent 60 antisense inhibitors 60 inhibits protein synthesis 60 pretransplant 60 ganciclovir 60 thrombocytopenic patients 60 syngeneic 60 MEK inhibitors 60 recurrent glioblastoma multiforme 60 bronchoalveolar lavage fluid 60 sPLA2 60 HbF 60 PKC# 60 oxysterols 60 Leydig cell 60 epoetin alpha 60 androgen dependent 60 primary hyperparathyroidism 60 immunotoxin 60 immunomodulatory therapies 60 leukemias lymphomas 60 myelosuppression 60 compound AEZS 60 serine proteases 60 EGFR receptor 60 peptidic 60 VEGF receptor 60 EGF receptors 60 lung adenocarcinomas 60 anticancer therapies 60 angiogenesis inhibitors 59 HER2 receptors 59 osteogenic 59 chemokine receptors 59 cyclic nucleotide 59 eflornithine 59 Granulocyte Colony Stimulating Factor 59 matrix metalloproteinases 59 neovascularisation 59 myeloid derived 59 lysosomal storage disease 59 receptor blocker 59 Cellcept 59 proteasome inhibitors 59 DNA intercalator 59 antineoplastic 59 bronchial epithelial cells 59 anemias 59 acadesine 59 Intra arterial 59 trastuzumab Herceptin ® 59 Vaprisol 59 cisplatin chemotherapy 59 receptor inhibitor 59 dose melphalan 59 ovarian carcinoma 59 metastatic gastric 59 biotherapies 59 Vidaza R 59 chemotherapeutic agent 59 Seliciclib 59 adenoviral 59 Onconase 59 Glypromate 59 5 Fluorouracil 59 Vandetanib 59 vWD 59 serpin 59 osteoblast 59 chronic viral infections 59 alefacept 59 antibody MAb 59 AEG# 59 bone morphogenetic protein 59 HER2 receptor 59 Vascular Endothelial Growth 59 iPS derived 59 murine models 59 intimal hyperplasia 59 thromboembolic disease 59 BChE 59 A1PI 59 MDCK 59 efaproxiral 59 thrombolytic agents 59 receptor antagonists 59 Noxafil 59 paricalcitol 59 leukocyte recruitment 59 CYT# potent vascular disrupting 59 therapeutic regimens 59 isoform selective 59 Upregulation 59 antiandrogens 59 intestinal epithelium 59 bone morphogenetic proteins BMPs 59 Immunotherapeutic 59 polymorphonuclear 59 Sezary syndrome 59 Neulasta R 59 CINTREDEKIN BESUDOTOX 59 endostatin 59 vascular disrupting agents 59 TGF ß1 59 targeted radiotherapeutic 59 Xanafide 59 insulin glulisine 59 p# biomarker 59 mitochondrial toxicity 59 lung fibrosis 59 TNFalpha 59 inducible nitric oxide synthase 59 docetaxel Taxotere 59 intravesical instillation 59 hepatotoxic 59 capsular polysaccharide 59 haematologic malignancies 59 etanercept Enbrel 59 mTOR mammalian target 59 protein misfolding diseases 59 HDAC enzyme 59 2DG 59 Clolar ® 59 sipuleucel T 59 beta adrenergic 59 multikinase inhibitor 59 lymphoid cells 59 G#DT 59 pancreatic islet 59 nutlin 3a 59 prostanoid 59 PC3 cells 59 adriamycin 59 bone morphogenetic proteins 59 torsade de pointes 59 Tß4 59 virotherapy 59 immunosuppressive agents 59 p# activation 59 MyVax ® 59 antitumor effect 59 sargramostim 59 bronchogenic carcinoma 59 P. acnes 59 dendritic cell vaccine 59 mAbs 59 FLT3 59 metastatic colorectal 59 PDGF receptor 59 TLK# 59 myeloablative 59 Hashimoto thyroiditis 59 adipose derived regenerative 59 sulindac 59 Anaplastic 59 gefitinib Iressa 59 cutaneous T 59 haematological cancers 59 antifungal drugs 59 Telintra 59 FVIIa 59 neuropsychiatric diseases 59 direct thrombin inhibitors 59 VEGF expression 59 subependymal giant cell 59 proximal tubular 59 DNA methyltransferases 59 eosinophil 59 visilizumab 59 orally bioavailable mimics 59 pemphigus vulgaris 59 anagrelide 59 allogenic 59 cediranib 59 somatostatin receptors 59 chemoresistant 59 lymphangiogenesis 59 radiolabeled TM# 59 Valproic acid 59 GRN#L 59 potent anticancer 59 HuLuc# 59 metastatic malignant melanoma 59 echinocandins 59 anticancer therapy 59 dihydrochloride 59 T#I [002] 59 immunoregulatory 59 denileukin diftitox 59 poloxamer 59 androgen hormone 59 liposomal amphotericin B 59 microglial 59 pDC 59 bacillus Calmette Guerin 59 replicase 59 lymphoid malignancies 59 myeloproliferative neoplasms 59 Beta catenin pathway 59 therapeutic monoclonal antibody 59 lymphocytic leukemia 59 transferrin receptors 59 KRAS oncogene 59 blood clotting protein 59 Mitoxantrone 59 hematological diseases 59 Filgrastim 59 opioid antagonists 59 NSCLC tumors 59 transplantation HSCT 59 YONDELIS 59 SGLT2 inhibitors 59 antimetabolite 59 papillary carcinoma 59 unresectable tumors 59 Omacetaxine 59 endothelial activation 59 retinoic acid receptor 59 MTP inhibitor 59 systemic amyloidosis 59 MYCN amplification 59 renal cell carcinomas 59 AT1R 59 Tissue Factor 59 Degarelix 59 Gliadel Wafer 59 cytopenias 59 metaplasia 59 endometrial hyperplasia 59 azacytidine 59 cynomolgus monkeys 59 cytotoxicity assays 59 antiplatelet therapies 59 adrenal suppression 59 bone morphogenic protein 59 hA# 59 renal fibrosis 59 GRNVAC1 59 leukocyte adhesion 59 TGF beta1 59 immunosuppressant drug 59 mycophenolate mofetil 59 Thrombin 59 thrombin receptor 59 Src inhibitors 59 TTR gene 59 MDSCs 59 immunoconjugate 59 pancreatic lung 59 PIGF 59 potent inducer 59 annexin 59 carcinoids 59 Velcade bortezomib 59 pancreatic alpha 59 Cyclosporine 59 cyclooxygenase 59 N. gonorrhoeae 59 essential thrombocythemia ET 59 cilengitide 58 PROCHYMAL 58 histone deacetylase HDAC 58 albumin bound paclitaxel 58 idiopathic pulmonary 58 beta lactamases 58 Interferon alfa 58 intestinal polyps 58 thyroid carcinoma 58 protein tyrosine phosphatase 1B 58 intravenous immunoglobulin 58 protein tyrosine 58 pDCs 58 amikacin 58 cell adhesion molecule 58 CD# antibody [001] 58 neural progenitor cells 58 haematological malignancies 58 circulating endothelial 58 cidofovir 58 HERCEPTIN 58 antiproliferative 58 parasitemia 58 fallopian tube cancers 58 Sjögren syndrome 58 human leukocyte antigens 58 topical retinoids 58 mda 7 58 anti infective treatments 58 pancreatic islet cell 58 temozolomide Temodar 58 gastric adenocarcinoma 58 treat chronic sinusitis 58 deletion 5q 58 Panzem 58 chemopreventive agent 58 cancerdefine 58 humanized antibody 58 corticosteroid therapy 58 stem cell pluripotency 58 potent stimulator 58 thiazide diuretic 58 alveolar epithelial cells 58 CDK inhibitor 58 #T# L1 58 diabetic gastroparesis 58 antifolates 58 rhGH 58 prostate adenocarcinoma 58 IGFBP 58 selective agonists 58 immunomodulatory therapy 58 gemcitabine Gemzar 58 pancreatic carcinoma 58 Apo2L 58 xenograft tumors 58 EGFR protein 58 cinacalcet 58 melanocytic nevi 58 sJIA 58 Glioblastoma Multiforme 58 lymphoproliferative disorder 58 SomatoKine 58 MYLOTARG 58 Prostaglandins 58 azoles 58 trastuzumab Herceptin 58 lymphocytic 58 somatostatin 58 SIR Spheres 58 Rituxan rituximab 58 fluconazole resistant 58 suppressor cells 58 Enzastaurin 58 intestinal mucosal 58 lipid lowering therapies 58 Tacrolimus 58 thiazolides 58 Parathyroid hormone 58 ganaxolone 58 vascular thrombosis 58 sodium glucose cotransporter 58 albumin protein 58 Insegia 58 receptor PPAR 58 nonhuman primate model 58 CEQ# 58 alkylating agents 58 Elevated serum 58 gastrointestinal stromal tumor 58 antiangiogenic 58 renal carcinoma 58 mucosal immunity 58 erythropoietin stimulating agents 58 Ceflatonin 58 V#F mutation 58 calcineurin inhibitors 58 antiandrogen 58 SERMs 58 selective inhibition 58 pulmonary hypertension PH 58 alpha1 antitrypsin deficiency 58 anticancer treatments 58 PPAR γ 58 M2 subunit 58 NAGS deficiency 58 relapsed ovarian cancer 58 histone deacetylase 58 lymphoid tissues 58 abacavir Ziagen 58 Camptothecin 58 fibrin matrix 58 tumorigenicity 58 cytotoxic T lymphocyte 58 bioscavenger 58 small molecule tyrosine 58 T#I mutant 58 SCIg 58 neurotrophins 58 targeted nucleotide prodrug 58 pyridoxine 58 hepatocellular carcinomas 58 superficial basal cell carcinoma 58 somatostatin analogue 58 NOD SCID mice 58 cathepsins 58 chemotherapeutic drug 58 sorafenib Nexavar 58 Copegus ribavirin 58 mastocytosis 58 acetylcholinesterase AChE 58 PARP inhibition 58 galiximab 58 Platinol ® 58 Doxil ® 58 mimetics 58 leucocytes 58 Factor Receptor 58 plasminogen activators 58 β1 58 nucleoside analogues 58 P#X# 58 grade gliomas 58 leukaemias 58 Mitomycin C 58 proto oncogene 58 cholangiocarcinoma 58 immunomodulators 58 Peptide YY 58 Cytochrome P# 58 gonococcal 58 lesional 58 novel VDA molecule 58 tubulin binding 58 Enkephalin 58 nonmelanoma skin cancers 58 phototoxicity 58 nephrotoxic drugs 58 squamous cell carcinoma SCC 58 IAP inhibitors 58 lenalidomide Revlimid R 58 GCSF 58 Dasatinib 58 PDGFR 58 HER2 overexpression 58 mycophenolate mofetil MMF 58 adalimumab Humira 58 idraparinux 58 GSK3 58 GPIIb IIIa 58 NKX2 58 monoclonal antibody therapies 58 cetuximab Erbitux ® 58 MCF7 58 plasma renin activity 58 B7 H3 58 E selectin 58 mimetic compounds 58 Trastuzumab 58 hMG 58 PDGF B 58 TELINTRA 58 Eli Lilly Gemzar 58 ß blockers 58 haematological 58 ASC J9 58 multiple myeloma MM 58 autologous transplants 58 IGFBP 3 58 fibrogenesis 58 hypoxia inducible factor 58 Epstein Barr Virus EBV 58 glioma cells 58 mycophenolate 58 Vidofludimus 58 tipranavir ritonavir 58 vinca alkaloid 58 idarubicin 58 glutathione peroxidase 58 selective modulator 58 cutaneous melanoma 58 tranilast 58 activate p# 58 TAT2 58 oncogenic transformation 58 TG# [003] 58 Chronic lymphocytic leukemia 58 colon carcinogenesis 58 TPMT 58 chlamydial 58 streptokinase 58 haematopoietic stem cell 58 IL 1ß 58 acetonide FA 58 bone marrow progenitor cells 58 atypical hemolytic uremic syndrome 58 CYP#A# enzyme 58 peptide antigens 58 breast pancreatic 58 Zolinza 58 immunoregulation 58 ADPKD 58 smoldering myeloma 58 triiodothyronine 58 immune suppressing 58 cysteamine bitartrate 58 acute coronary syndromes ACS 58 thymidylate synthase TS 58 Inosine 58 c myc gene 58 intravenous immunoglobulin IVIG 58 Gemzar gemcitabine 58 monoclonal antibody conjugated 58 cell lymphoma CTCL 58 serotonin uptake 58 PI3K/mTOR 58 Belldegrun 58 ibritumomab tiuxetan 58 GM CSF 58 recombinant FVIII 58 neuroinflammatory 58 PI3K AKT 58 beta arrestin 58 inhibiting COX 58 HER2 positive cancers 58 nucleotide analog 58 cleavable linker 58 JAK3 58 mutated K ras 58 sigma receptor 58 coagulation disorders 58 hemolytic 58 antiepileptics 58 inhibit enzymes 58 transgene expression 58 RANK ligand 58 inverse agonist 58 lactate dehydrogenase 58 glycated 58 antifungal agents 58 bone marrow derived mesenchymal 58 Tyrosine Kinase Inhibitors 58 activated lymphocytes 58 osteosarcomas 58 Pathway Inhibitor 58 anti CD# antibodies 58 Monoclonal antibody 58 serotonin receptor 58 Acute myeloid leukemia 58 antifibrotic 58 gastrointestinal stromal tumors GIST 58 miRs 58 novel immunotherapeutic 58 histone deacetylases 58 castrate resistant prostate cancer 58 leukemia ALL 58 potently inhibited 58 kinase inhibition 58 nasopharyngeal carcinoma 58 glucocorticoid receptors 58 sarcomatoid 58 G CSF 58 immunological diseases 58 cardio renal 58 HBV vaccine 58 induce pluripotency 58 polycystin 58 gastrin 58 annexin V 58 factor PlGF 58 Androgens 58 VEGF vascular endothelial 58 growth hormone secretion 57 hepatorenal syndrome 57 neuroendocrine carcinoma 57 neutropenic 57 lymphocyte activation 57 anticholinergic agents 57 GPx 57 superantigens 57 PPARγ 57 IAP inhibitor 57 myeloid metaplasia 57 thymidine kinase 57 Campath ® 57 PhG alpha 1 57 docetaxel Taxotere R 57 surgically resectable 57 caspofungin 57 pDNA vaccines 57 receptor inhibitors 57 RNAi therapeutic targeting 57 Omalizumab 57 myeloma cells 57 EGFr 57 cardiac glycosides 57 ptau 57 BrachySil ™ 57 CTLs 57 Liprotamase 57 pyridostigmine 57 immune globulins 57 vivo validation 57 relapsed leukemia 57 Cx# [002] 57 dermal collagen 57 FXIII 57 cyclic adenosine monophosphate cAMP 57 somatostatin analogues 57 lymphocyte counts 57 uPAR 57 ENMD # 57 imatinib Gleevec ® 57 mitomycin 57 mGluR5 antagonist 57 Clusterin 57 relapsed MM 57 LTB4 57 CD8 + 57 demonstrated antitumor activity 57 chemopreventive agents 57 CCR2 57 chronic eosinophilic leukemia 57 NFκB 57 insulin sensitizers 57 Gorlin syndrome 57 suppresses tumor 57 LEP ETU 57 neoplastic 57 thrombotic complications 57 rituximab Rituxan ® 57 Cancidas 57 sCD# 57 acute GvHD 57 IL# PE 57 CCL# 57 oncomodulin 57 antithrombotics 57 CLL SLL 57 ABCG2 57 histologic subtype 57 leukemia AML 57 beta adrenergic receptors 57 Azacitidine 57 conventional DMARDs 57 neuroendocrine tumors 57 poly ADP ribose polymerase 57 AST ALT 57 cholecystokinin CCK 57 adipose tissue fat 57 immuno inflammatory 57 Galectin 57 oncological indications 57 antiangiogenesis 57 Photodynamic Therapy PDT 57 panobinostat 57 bladder carcinoma 57 serum urate levels 57 octreotide LAR 57 Spironolactone 57 YONDELIS R 57 receptor subtypes 57 Anticalins ® 57 autologous transplantation 57 candidemia 57 IL# PE#QQR 57 ADP receptor antagonist 57 diabetic kidney